Nutritional therapy in chronic kidney disease

Nutrition in Clinical Care

Volumn 8, Issue 2, 2005, Pages 70-76

  Savica, Vincenzo ^a,b   Santoro, Domenico ^a   Ciolino, Francesco ^a   Mallamace, Agostino ^a   Calvani, Menotti ^a   Savica, Rodolfo ^a   Bellinghieri, Guido ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b NONE   (Italy)

Author keywords

Chronic kidney disease; CKD; Kidney

Indexed keywords

CHRONIC KIDNEY DISEASE; DIET THERAPY; ELECTROLYTE DISTURBANCE; HUMAN; MORBIDITY; MORTALITY; REVIEW; RISK ASSESSMENT; VITAMIN DEFICIENCY; ADOLESCENT; ADULT; CHILD; CHRONIC KIDNEY FAILURE; DIET SUPPLEMENTATION; FEMALE; MALE; NUTRITIONAL DISORDER; NUTRITIONAL REQUIREMENT; NUTRITIONAL STATUS; PROTEIN RESTRICTION;

MINERAL; VITAMIN;

ADOLESCENT; ADULT; CHILD; DIET, PROTEIN-RESTRICTED; DIETARY SUPPLEMENTS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MINERALS; NUTRITION DISORDERS; NUTRITIONAL REQUIREMENTS; NUTRITIONAL STATUS; VITAMINS;

EID: 24344475690     PISSN: 10966781     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Ford-Martin PA. Chronic kidney failure. In: Olendorf D, Jeryan C, Boyden K, eds. Gale Encyclopedia of Medicine. Farmington Hills, MI: Thomson Gale; 2002: 1-6.
2. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003;41:1-12.
3. Kopple JD, Zhu X, Lew NL, Lowrie EG. Body weight for height relationships predict mortality in maintenance hemodialysis patients. Kidney Int. 1999;56:1136-1148.
4. Curchill DN, Taylor DW, Keshaviah PR; CANUSA Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol. 1996;7:198-207.
5. Qureshi AR, Alvestrand A, Danielsson A, et al. Factors predicting malnutrition in hemodialysis patients: a cross-sectional study. Kidney Int. 1998;53:773-782.
6. Stenvinkel P, Barany P, Chung SH, Lindholm B, Heimburger O. A comparative analysis of nutritional parameters as predictors of outcome in male and female ESRD patients. Nephrol Dial Transplant. 2002;17:1266-1274.
7. Savica V, Ciolino F, Gattarello G, Santoro D, Bellinghieri G. Nutritional status in patients dialyzed for more than 20 years. Aktuality v Nefrologii. 2003;16-17.
8. Kalantar Zadeh K, Kopple JD, Block G, Hunphreys MH. A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis. 2001;38:1251-1263.
9. Graham KA, Reaich D, Channon SM, et al. Correction of acidosis in CAPD decreases whole body protein degradation. Kidney Int. 1996;49:1396-1400.
10. Reaich D, Channon SM, Scrimgeour CM, Daley SE, Wilkinson R, Goodship TH. Correction of acidosis in humans with CRF decreases protein degradation and amino acid oxidation. Am J Physiol. 1993;265(2 part 1):E230-E235.
11. Kaysen GA. Inflammation nutritional state and outcome in end-stage renal disease. Min Electrolyte Metab. 1999;25:242-250.
12. Savica V, Santoro D, Mazzaglia G, et al. L-carnitine may suppress serum C-reactive protein and improve nutritional status in maintenance hemodialysis patients. J Ren Nutr. 2005;15:225-230.
13. Bellinghieri G, Santoro D, Calvani M, Savica V. Role of carnitine in modulating acute-phase protein synthesis in hemodialysis patients. J Ren Nutr. 2005;15:13-17.
14. Savica V, Calvani M, Benfatti P, et al. Carnitine system in uremic patients: molecular and clinical aspects. Semin Nephrol. 2004;24:464-468.
15. Barsotti G. Effects of dietary therapy on uremic symptoms and complications. In: Giovannetti S, ed. Nutritional Treatment of Chronic Renal Failure. Boston: Kluwer Academic Publishers; 1989:33-40.
16. Furst P, Alvestrand A, Bergstrom J. Recent advances in the pathogenesis and nutritional treatment of chronic uremia. Z Ernahrungswiss. 1982;21:175-190.
17. Brenner BM, Meyer TW, Hostetter TH. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med. 1982;307:652-659.
18. Teschner M, Bahner V, Heidland A. Progressionsverhutung der chronischen niereninsufficienz. Dtsch Med Wschr. 1987;112:3533-3538.
19. Pedrini MT, Levey AS, Lau J, Chalmers TC, Wang PH. The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta-analysis. Ann Intern Med. 1996;124:627-632.
20. Fouque D, Laville M, Boissel JP, Chifflet R, Labeeuw M, Zech PY. Controlled low protein diets in chronic renal insufficiency: meta-analysis. BMJ. 1992;304:216-220.
21. Fouque D, Wang P, Laville M, Boissel JP. Low protein diets delay end-stage renal disease in non-diabetic adults with chronic renal failure. Nephrol Dial Transplant. 2000;15:1986-1992.
22. US Department of Agriculture, Agricultural Research Service. Food and Nutrient Intakes by Individuals in the United States, by Sex and Age, 1994-96. Available online at: http://www.barc.usda.gov/bhnrc/foodsurvey/pdf/Supp.pdf. Accessed May 5, 2005.
23. Kopple JD, Levey AS, Greene T, et al. Effect of dietary protein restriction on nutritional status in the Modification of Diet in Renal Disease Study. Kidney Int. 1997;52:778-791.
24. Frohling PT, Kokot F, Schmicker R, Kaschube I, Lindenau K, Vetter K. Influence of keto acids on serum parathyroid hormone levels in patients with chronic renal failure. Clin Nephrol. 1988;20:212-215.
25. Schaefer K, von Herrath D, Asmus G, Umlauf E. The beneficial effect of ketoacids on serum phosphate and parathyroid hormone in patients with chronic uremia. Clin Nephrol. 1988;30:93-96.
26. Malvy D, Maingourd C, Pengloan J, Bagros P, Nivet H. Effects of severe protein restriction with keto-analogues in advanced renal failure. J Am Coll Nutr. 1999;18:481-486.
27. Muntner P, Hamm LL, Kusek JW, Chen J, Whelton PK, He J. The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kid-ney disease. Ann Intern Med. 2004;140:9-17.
28. Taccone-Gallucci M, Lubrano R, Meloni C. Vitamin E as an antioxidant agent. Contrib Nephrol. 1999;127:32-43.
29. Miller ER 3rd, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: High-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med. 2005;142:37-46.
30. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
31. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UK-PDS 33). Lancet. 1998;352:837-53
32. Fried LF, Orchard TJ, Kasiske BL. Effect of lipid reduction on the progression of renal disease: a meta-analysis. Kidney Int. 2001;59:260-269.